FDAnews Device Daily Bulletin

FDA OKs Hologic, Inc. (HOLX)’s Aptima Trichomonas

Jan. 16, 2013
A A
Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has cleared for marketing its APTIMA Trichomonas vaginalis Assay on the Company's fully-automated PANTHER System.
DeviceSpace